Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001415889-25-018365

Options or other derivatives

  • CEO and Chairman acquired 83,296,638 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kress Jean-Paul CEO and Chairman 2025-06-26 Grant or award · Employee Stock Option (right to buy) +83,296,638 83,296,638 D
Loading xslF345X05/form4-06272025_080605.xml…